Condition: Ductal Carcinoma in Situ · Invasive Ductal Carcinoma of Female Breast · Sponsor: RPCR, Inc.
This is a multi-institutional, prospective, observational registry investigating the safety and efficacy of Accelerated Partial Breast Irradiation (APBI) using a Stereotactic Body Radiation Therapy (SBRT) delivery technique that incorporates real-time image guidance, noncoplanar fields, and respiratory tracking. The study will accrue 200 patients who will be treated to a dose of 30 Gy over the course of 5 fractions. These subjects will then have a follow up time of 5 years
This description comes directly from the study's public registry record.
Mark Perman, MD · 772-293-0377 · Mark.Perman@usa.genesiscare.com
Debra Freeman, MD · 239-262-5168 · tbck.md@gmail.com
Always discuss trial participation with your own doctor first.
| CyberKnife Center of South Florida in Stuart | Stuart, Florida, United States | Recruiting |
| CyberKnife Centers of Tampa Bay | Tampa, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04985032